Varlilumab is the company’s fully human monoclonal agonist antibody that binds and activates CD27, a critical co-stimulatory molecule in the immune activation cascade. The Phase I portion of
Synjardy is a combination of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, and metformin hydrochloride (HCl), commonly prescribed to treat T2D. In the EU, empagliflozin was approved
Mircera is used to treat symptomatic anaemia associated with chronic kidney disease (CKD) in adult patients. The company said that the drug represents a complement to its existing
Zafatek (trelagliptin succinate) controls blood glucose levels by selectively and continually inhibiting DPP-4, an enzyme that causes the inactivation of glucagon-like peptide-1 and glucagon-dependent insulinotropic polypeptide, incretin hormones
VT-464 is an oral medication given without prednisone that may represent an improved therapy for men with CRPC and it works by selectively inhibiting CYP17 lyase, a target
MERS is caused by a coronavirus, which is related to the severe acute respiratory syndrome (SARS) virus and currently there is no vaccine or effective treatment for this
Fycompa is indicated to treat PGTC seizures in adult and adolescent patients from 12 years of age with idiopathic generalized epilepsy. Discovered and developed by Eisai, Fycompa is
The approval was based on data from three Phase III studies, TARGET 1, TARGET 2 and TARGET 3 involving more than 3,000 patients. In these trials, Xifaxan 550mg
The drug is indicated for ADPKD patients who have chronic kidney disease (CKD) stage one to three at initiation of treatment with evidence of rapidly progressing disease. Tolvaptan
The company said that Viberzi has mixed opioid receptor activity, it is a mu receptor agonist, a delta receptor antagonist and a kappa receptor agonist. IBS-D is characterized
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.